The palladacycle, BTC2, exhibits anti-breast cancer and breast cancer stem cell activity.
Biochem Pharmacol
; 190: 114598, 2021 08.
Article
in En
| MEDLINE
| ID: mdl-33979647
Key words
1,2-bis(diphenylphosphino)ethane (PubChem CID: 74267);; 2,6 di-isopropylaniline (PubChem:ID: 32484); 2-(2-Chloroethoxy)ethanol (PubChem CID: 12361); 4-[2-(2-hydroxyethoxy)ethoxy]benzaldehyde (PubChem CID: 11206592); 4-hydroxybenzaldehyde (PubChem CID: 126); Anti-migration; Apoptosis; Cytotoxicity; DNA damage; Dimethyl sulfoxide (PubChem CID: 679); Mitomycin C (PubChem CID: 5746); Necroptosis; Paclitaxel (PubChem CID: 36314); Palladacycles; Palladium (PubChem CID: 23938); acetonitrile (PubChem CID: 6342; bis(acetonitrile)palladium dichloride (PubChem CID: 6093782); dichloromethane (PubChem CID: 61344); sodium acetate (PubChem CID: 517045)
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Palladium
/
Neoplastic Stem Cells
/
Breast Neoplasms
/
Antineoplastic Agents, Phytogenic
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Biochem Pharmacol
Year:
2021
Document type:
Article
Affiliation country:
Sudáfrica
Country of publication:
Reino Unido